Promise and pitfalls in animal-based asthma research: Building a better mousetrap

Immunologic Research

Volumn 35, Issue 3, 2006, Pages 279-294

  Corry, David B ^a   Irvin, Charles G ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Airway hyperresponsiveness; Animal model; Asthma; TH2 cell

Indexed keywords

ALLERGEN; ANTIGEN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE; OMALIZUMAB;

AIRWAY RESISTANCE; ALLERGIC ASTHMA; ASTHMA; B LYMPHOCYTE; CLINICAL FEATURE; DISEASE MODEL; EOSINOPHIL; GENETIC HETEROGENEITY; HUMAN; INHALATION TEST; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYMPTOM; TH1 CELL; TH2 CELL;

ANIMAL EXPERIMENTATION; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; HUMANS; RESEARCH DESIGN;

EID: 33845870421     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:35:3:279     Document Type: Review

References (110)

1. Mannino DM, et al: Surveillance for asthma - United States, 1980-1999. MMWR 2002;51:1-13.
2. Holgate ST: The epidemic of allergy and asthma. Nature 1999;402:B2-4.
3. Kips JC, et al: Murine models of asthma. Eur Respir J 2003;22:374-382.
4. Coffman RL, Hessel EM: Nonhuman primate models of asthma. J Exp Med 2005;201:1875-1879.
5. Boyce JA, Austen KF: No audible wheezing: nuggets and conundrums from mouse asthma models. J Exp Med 2005;201:1869-1873.
6. Kumar RK, Foster PS: Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 2002;3:267-272.
7. Persson CG: Con: mice are not a good model of human airway disease. Am J Respir Crit Care Med 2002;166: 6-7.
8. Gelfand EW: Pro: mice are a good model of human airway disease. Am J Respir Crit Care Med 2002;166: 5-6.
9. Vargaftig BB: What can we learn from murine models of asthma? Clin Exp Allergy 1999;29:9-13.
10. Persson CG, Erjefalt JS, Korsgren M, Sundler F. The mouse trap. Trends Pharmacol Sci 1997;18:465-467.
11. Wanner A, et al: NHLBI Workshop Summary. Models of airway hyperresponsiveness. Am Rev Respir Dis 1990;141:253-257.
12. Peat JK, Salome CM, Woolcock AJ: Factors associated with bronchial hyperresponsiveness in Australian adults and children. Eur Respir J 1992;5:921-929.
13. Sporik R, Holgate ST, Cogswell JJ: Natural history of asthma in childhood - a birth cohort study. Arch Dis Child 1991;66:1050-1053.
14. Otani K, et al: Determinants of the severity of exercise-induced bronchoconstriction in patients with asthma. J Asthma 2004;41:271-278.
15. Hallstrand TS, Ault KA, Bates PW, Mitchell J, Schoene RB: Peripheral blood manifestations of T(H)2 lymphocyte activation in stable atopic asthma and during exercise-induced bronchospasm. Ann Allergy Asthma Immunol 1998;80:424-432.
16. Ying S, et al: Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997;158:3539-3544.
17. Robinson DS, et al: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
18. Kheradmand F, et al: A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 2002;169:5904-5911.
19. Pepys J, Wells ID, D'Souza MF, Greenberg M: Clinical and immunological responses to enzymes of Bacillus subtilis in factory workers and consumers. Clin Allergy 1973;3:143-160.
20. Park HS, Kim HY, Lee SK, Kim SS, Nahm DH: Diverse profiles of specific IgE response to toluene diisocyanate (TDI)-human serum albumin conjugate in TDI-induced asthma patients. J Korean Med Sci 2001;16:57-61.
21. Herrick CA, et al: Differential roles for CD4 and CD8 T cells after diisocyanate sensitization: genetic control of TH2-induced lung inflammation. J Allergy Clin Immunol 2003;111:1087-1094.
22. Leung DY, et al: Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 1995;181:33-40.
23. Naseer T, et al: Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997;155: 845-851.
24. Leung DYM, Spahn JD, Szefler SJ: Steroid-unresponsive asthma. Semin Respir Crit Care Med 2002;23: 387-398.
25. Rasmussen F, et al: Outcome in adulthood of asymptomatic airway hyperresponsiveness in childhood: a longitudinal population study. Pediatr Pulmonol 2002;34:164-171.
26. Porsbjerg C, von Linstow M-L, Ulrik CS, Nepper-Christensen SC, Backer V: Outcome in adulthood of asymptomatic airway hyperresponsiveness to histamine and exercise-induced bronchospasm in childhood. Ann Allergy Asthma Immunol 2005;95:137-142.
27. Berry MA, et al: Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy 2005;35:598-601.
28. Coyle AJ, Kohler G, Tsuyuki S, Brombacher F, Kopf M: Eosinophils are not required to induce airway hyperresponsiveness after nematode infection. Eur J Immunol 1998;28:2640-2647.
29. Buijs J, Lokhorst WH, Robinson J, Nijkamp FP: Toxocara canis-induced murine pulmonary inflammation: analysis of cells and proteins in lung tissue and bronchoalveolar lavage fluid. Parasite Immunol 1994;16: 1-9.
30. Johansson SG: Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet 1967;2:951-953.
31. Marsh WR, Irvin CG, Murphy KR, Behrens BL, Larsen GL: Increases in airway reactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in an animal model. Am Rev Respir Dis 1985;131:875-879.
32. Dunn CJ, Elliott GA, Oostveen JA, Richards IM: Development of a prolonged eosinophil-rich inflammatory leukocyte infiltration in the guinea-pig asthmatic response to ovalbumin inhalation. Am Rev Respir Dis 1988;137:541-547.
33. Bousquet J, Chanez P, Lacoste JY, et al: Eosinophilic inflammation in asthma. N Engl J Med 1990;323: 1033-1039.
34. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136: 2348-2357.
35. Clutterbuck EJ, Hirst EM, Sanderson CJ: Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 1989;73:1504-1512.
36. Ohara J, Paul WE: Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage. Nature 1987;325:537-540.
37. Wills-Karp M, et al: Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-2261.
38. Grunig G, et al: Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998;282: 2261-2263.
39. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ: Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998;187:939-948.
40. Hansen G, Berry G, DeKruyff RH, Umetsu DT: Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103:175-183.
41. Drouin SM, Corry DB, Hollman TJ, Kildsgaard J, Wetsel RA: Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol 2002;169:5926-5933.
42. Xu J, Park PW, Kheradmand F, Corry DB: Endogenous attenuation of allergic lung inflammation by syndecan-1. J Immunol 2005;174:5758-5765.
43. Akbari O, et al: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002;8:1024-1032.
44. Kunikata T, et al: Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat Immunol 2005;6:524-531.
45. Salek-Ardakani S, et al: OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med 2003;198:315-324.
46. Tumas DB, et al: Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization. J Allergy Clin Immunol 2001;107:1025-1033.
47. Turner CR, et al: In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma. J Clin Invest 1996;97:381-387.
48. Henderson WR, Jr, et al: The importance of leuko trienes in airway inflammation in a mouse model of asthma. J Exp Med 1996;184:1483-1494.
49. Underwood DC, Osborn RR, Newsholme SJ, Torphy TJ, Hay DW: Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am J Respir Crit Care Med 1996;154:850-857.
50. Grimes D, et al: WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity. Eur J Pharmacol 1993;236:217-228.
51. Iwama T, Nagai H, Koda A: Effects of NZ-107 on airway inflammation and cell activation in guinea-pigs. J Pharm Pharmacol 1993;45:286-291.
52. Chang J, Musser JH, Hand JM: Effect of a novel leukotriene D4 antagonist with 5-lipoxygenase and cyclooxygenase inhibitory activity, Wy-45,911, on leukotriene-D4-and antigen-induced bronchoconstriction in the guinea pig. Int Arch Allergy Appl Immunol 1988;86:48-54.
53. Ishizaka K, Tomioka H, Ishizaka T: Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes. J Immunol 1970; 105:1459-1467.
54. Tomioka H, Ishizaka K: Mechanisms of passive sensitization. II. Presence of receptors for IgE on monkey mast cells. J Immunol 1971;107:971-978.
55. Ishizaka T, Tomioka H, Ishizaka K: Degranulation of human basophil leukocytes by anti-gamma E antibody. J Immunol 1971;106:705-710.
56. Lack G, et al: Transfer of immediate hypersensitivity and airway hyperresponsiveness by IgE-positive B cells. Am J Respir Crit Care Med 1995;152:1765-1773.
57. Renz H, et al: Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol 1992;89:1127-1138.
58. Mehlhop PD, et al: Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA 1997;94:1344-1349.
59. Corry DB, et al: Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 1998;4:344-355.
60. MacLean JA, Sauty A, Luster AD, Drazen JM, De Sanctis GT: Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B cell-deficient mice. Am J Respir Cell Mol Biol 1999;20:379-387;
61. Milgrom H, et al: Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med 1999;341:1966-1973.
62. Djukanovic R, et al: Effects of treatment with antiimmunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2004;170:583-593.
63. Finn A, et al: Omalizumab improves asthma-related quality of life in patients with severe allergic asthma. J Allergy Clin Immunol 2003;111:278-284.
64. Milgrom H, et al: Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics 2001;108:E36.
65. Corren J, Casale T, Deniz Y, Ashby M: Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. J Allergy Clin Immunol 2003;111:87-90.
66. Basta M, et al: F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med 2003;9:431-438.
67. Flavahan NA, Slifman NR, Gleich GJ, Vanhoutte PM: Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle: role of the epitheilum. Am Rev Respir Dis 1988;138:685-688.
68. Uchida DA, et al: The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am Rev Respir Dis 1993;147:982-988.
69. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D: Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989;245: 308-310.
70. Lilly CM, et al: Effects of interleukin 5-induced pulmonary eosinophilia on airway reactivity in the guinea pig. Am J Physiol 1996;270:L368-375.
71. Corry DB, et al: Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996;183:109-117.
72. Humbles AA, et al: A critical role for eosinophils in allergic airways remodeling. Science 2004;305:1776-1779.
73. Tanaka H, Nagai H, Maeda Y: Effect of anti-IL-4 and anti-IL-5 antibodies on allergic airway hyperresponsiveness in mice. Life Sci 1998;62:L169-174.
74. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG: Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
75. Hogan SP, Koskinen A, Matthaei KI, Young IG, Foster PS: Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergeninduced eosinophilia, bronchial hyperreactivity, and lung damage in mice. American J Respir Crit Care Med 1998;157:210-218.
76. Lee JJ, et al: Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2005;305: 1773-1776.
77. Lee JJ et al: Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 1997;185: 2143-2156.
78. Leckie MJ et al: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148.
79. Kips JC, et al: Effect of SCH55700, a humanized antihuman interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med 2003;167:1655-1659.
80. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS: Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167:199-204.
81. Hogaboam CM, et al: Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 2000;156:723-732.
82. Adler A, Cieslewicz G, Irvin CG: Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J Appl Physiol 2004;97:286-292.
83. Hamelmann E, et al: Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a murine model of airway sensitization. J Exp Med 1996;183:1719-1729.
84. Zhang Y, Rogers KH, Lewis DB: Beta 2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J Exp Med 1996;184:1507-1512.
85. Kumagai K, et al: Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol 1999;162:4212-4219.
86. Corry DB, et al: Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol 2002;3: 347-353.
87. Lahn M, et al: Negative regulation of airway responsiveness that is dependent on gammadelta T cells and independent of alphabeta T cells. Nat Med 1999;5: 1150-1156.
88. Zuany-Amorim C, et al: Requirement for gammadelta T cells in allergic airway inflammation. Science 1998;280:1265-1267.
89. Akbari O, et al: Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003;9:582-588.
90. Borish LC, et al: Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999; 160:1816-1823.
91. Bryan SA, et al: Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2149-2153.
92. Gavett SH, et al: Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527-1536.
93. Bates J, et al: The use and misuse of penh in animal models of lung disease. Am J Respir Cell Mol Biol 2004;31:373-374.
94. Bates JH, Irvin CG: Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol 2003;94:1297-1306.
95. Tedeschi A, Comi AL, Lorini M, Tosini C, Miadonna A: Autologous serum skin test reactivity in patients with non-allergic asthma. Clin Exp Allergy 2005;35:8 49-853.
96. Blackburn MR, et al: Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med 2000;192:159-170.
97. Finotto S, et al: Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002;295:336-338.
98. Zhu Z, et al: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-788.
99. Fainaru O, Shseyov D, Hantisteanu S, Groner Y: Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc Natl Acad Sci USA 2005;102:10598-10603.
100. Dent AL, Hu-Li J, Paul WE, Staudt LM: T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proc Natl Acad Sci USA 1998;95:13823-13828.
101. Wu W, et al: Cellular FLIP long form-transgenic mice manifest a Th2 cytokine bias and enhanced allergic airway inflammation. J Immunol 2004;172:4724-4732.
102. Dale HH, Laidlaw PP: The physiological action of iminazolylethylamine. J Physiol 1910;41:318-344.
103. Hamelmann E, et al: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997;156:766-775.
104. Lundblad LK, Irvin CG, Adler A, Bates JH: A reevaluation of the validity of unrestrained plethysmography in mice. J Appl Physiol 2002;93:1198-1207.
105. Murphy KM, Heimberger AB, Loh DY: Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 1990;250:1720-1723.
106. Yiamouyiannis CA, et al: Shifts in lung lymphocyte profiles correlate with the sequential development of acute allergic and chronic tolerant stages in a murine asthma model. Am J Path 1999;154:1911-1921.
107. Shinagawa K, Kojima M: Mouse model of airway remodeling: strain differences. Am J Respir Crit Care Med 2003;168:959-967.
108. Murali PS, Dai G, Kumar A, Fink JN, Kurup VP: Aspergillus antigen-induced eosinophil differentiation in a murine model. Infection Immunity 1992;60: 1952-1956.
109. Sabater JR, Wanner A, Abraham WM: Montelukast prevents antigen-induced mucociliary dysfunction in sheep. Am J Respir Crit Care Med 2002;166: 1457-1460.
110. Borish LC, et al: Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol 2001;107:963-970.